Carmine SELLERI | Publications

47060The human complement receptor type 2/factor H fusion protein TT30, an alternative pathway specific complement inhibitor, prevents hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria by membrane-targeting of factor H activity.

	2010
	Abstract in rivista
	The human complement receptor type 2/factor H fusion protein TT30, an alternative pathway specific complement inhibitor, prevents hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria by membrane-targeting of factor H activity. MOLECULAR IMMUNOLOGY. Vol. 47. Pag.2215-2215 ISSN:0161-5890.
	Risitano, Am; Pascariello, C; Selleri, Carmine; Del Vecchio, L; Sica, M; Fridkis Hareli, M.
	Show it in Product Database (IRIS)

47007A candidate complement inhibitor for the treatment of paroxysmal nocturnal haemoglobinuria (PNH): preclinical data with tt30, a therapeutic that selectively blocks the complement alternative pathway.

	2010
	Abstract in rivista
	A candidate complement inhibitor for the treatment of paroxysmal nocturnal haemoglobinuria (PNH): preclinical data with tt30, a therapeutic that selectively blocks the complement alternative pathway. BONE MARROW TRANSPLANTATION. Vol. 45. Pag.116-116 ISSN:0268-3369.
	Pascariello, C; Selleri, Carmine; Del Vecchio, L; Hovarth, Cj; Holers, Vm; Risitano, A. M.
	Codice identificativo ISI: WOS:000277611300413
	Show it in Product Database (IRIS)

47134A novel approach to cell targeted complement inhibition in PNH: the human complement receptor 2/Factor H fusion protein TT30 prevents both hemolysis and upstream C3-opsonization of PNH erythrocytes

	2010
	Abstract in rivista
	A novel approach to cell targeted complement inhibition in PNH: the human complement receptor 2/Factor H fusion protein TT30 prevents both hemolysis and upstream C3-opsonization of PNH erythrocytes HAEMATOLOGICA. Pag.245-245 ISSN:0390-6078.
	Pascariello, C; Selleri, Carmine; Del Vecchio, L; Sica, M; Horvath, C; Holers, M.
	Codice identificativo ISI: WOS:000279051300588
	Show it in Product Database (IRIS)

38497Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA.

	2010
	Articolo in rivista
	Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA. BRITISH JOURNAL OF HAEMATOLOGY. Vol. 148. Pag.791-796 ISSN:0007-1048.
	Risitano, Am; Selleri, Carmine; Serio, B; Torelli, Gf; Kulagin, A; Maury, S; Halter, J; Gupta, V; Bacigalupo, A; Sociè, G; Tichelli, A; Schrezenmeier, H; Marsh, J; Passweg, J; Rotoli, B.
	Codice identificativo ISI: WOS:000274407200011 Codice identificativo SCOPUS: 2-s2.0-76449093834
	Show it in Product Database (IRIS)

51429Imatinib Is Safe and Effective In Patients with Refractory Chronic Graft Versus Host Disease: Analysis of Two Consecutive Prospective GITMO Studies

	2010
	Articolo in rivista
	Imatinib Is Safe and Effective In Patients with Refractory Chronic Graft Versus Host Disease: Analysis of Two Consecutive Prospective GITMO Studies BLOOD. Vol. 116. Pag.113-114 ISSN:0006-4971.
	Olivieri, A; Cimminiello, M; Locatelli, F; Zecca, M; Corradini, P; Patriarca, F; Mordini, N; Iacopino, P; Donelli, A; Selleri, Carmine; Badiali, M; Lucchini, G; Gini, G; Leoni, P; Bosi, A; Bacigalupo, A.
	Codice identificativo ISI: WOS:000289662200247
	Show it in Product Database (IRIS)